The Preimplantation Genetic Screening (PGS) Technology market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our researcher's latest study, due to COVID-19 pandemic, the global Preimplantation Genetic Screening (PGS) Technology market size is estimated to be worth US$ million in 2021 and is forecast to a readjusted size of USD million by 2028 with a CAGR of % during review period. Maternity Centers & Fertility Clinics accounting for % of the Preimplantation Genetic Screening (PGS) Technology global market in 2021, is projected to value USD million by 2028, growing at a % CAGR in next six years. While Next-generation Sequencing segment is altered to a % CAGR between 2022 and 2028.
Global key companies of Preimplantation Genetic Screening (PGS) Technology include Illumina, Thermo Fisher Scientific, Agilent Technologies, PerkinElmer, and Coopersurgical, etc. In terms of revenue, the global top four players hold a share over % in 2021.

Market segmentation

Preimplantation Genetic Screening (PGS) Technology market is split by Type and by Application. For the period 2017-2028, the growth among segments provide accurate calculations and forecasts for revenue by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
Next-generation Sequencing
Polymerase Chain Reaction
Fluorescence in Situ Hybridization
Comparative Genomic Hybridization
Single-nucleotide Polymorphism
Market segment by Application, can be divided into
Maternity Centers & Fertility Clinics
Hospitals
Research Laboratories & Academic Institutes
Others
Market segment by players, this report covers
Illumina
Thermo Fisher Scientific
Agilent Technologies
PerkinElmer
Coopersurgical
Natera
Takara Bio
Oxford Gene Technology
INVICTA
Genea
Progenesis
Igenomix
Reproductive Health and Wellness Center
Market segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia, and Rest of Asia-Pacific)
South America (Brazil, Argentina, Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 12 chapters:
Chapter 1, to describe Preimplantation Genetic Screening (PGS) Technology product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top players of Preimplantation Genetic Screening (PGS) Technology, with revenue, gross margin and global market share of Preimplantation Genetic Screening (PGS) Technology from 2019 to 2022.
Chapter 3, the Preimplantation Genetic Screening (PGS) Technology competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and application, with revenue and growth rate by Type, application, from 2017 to 2028.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2017 to 2022.and Preimplantation Genetic Screening (PGS) Technology market forecast, by regions, type and application, with revenue, from 2023 to 2028.
Chapter 11 and 12, to describe Preimplantation Genetic Screening (PGS) Technology research findings and conclusion, appendix and data source.